Electronic cigarettes for smoking cessation: a randomised controlled trial

  title={Electronic cigarettes for smoking cessation: a randomised controlled trial},
  author={Chris Bullen and Colin Howe and Murray Laugesen and Hayden J McRobbie and Varsha Parag and Jonathan A. Williman and Natalie Walker},
  journal={The Lancet},

Figures and Tables from this paper

A longitudinal analysis of electronic cigarette use and smoking cessation.
A longitudinal analysis of a national sample of current US smokers to determine whether e-cigarettes use predicted successful quitting, or reduced cigarette consumption, found that e-cigarette users were less likely to have quit at 7 months than non-users.
Electronic nicotine devices to aid smoking cessation by alcohol- and drug-dependent clients: protocol for a pilot randomised controlled trial
This is the first randomised controlled trial to assess the effectiveness and acceptability of ENDs within a population dependent on AOD, a priority group with very high levels of smoking.
Electronic Cigarettes for Smoking Cessation
  • C. Bullen
  • Medicine
    Current Cardiology Reports
  • 2014
If patients who smoke are unwilling to quit or cannot succeed using evidence-based approaches, e-cigarettes may be an option to be considered after discussing the limitations of current knowledge.
Predicting Short-Term Uptake of Electronic Cigarettes: Effects of Nicotine, Subjective Effects, and Simulated Demand
Introduction E-cigarettes have potential to support tobacco cessation or reduction, but how nicotine content affects smokers' subjective perceptions and use of e-cigarettes, rather than tobacco, is
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials
The use of e-cigarettes as a therapeutic intervention for smoking cessation may lead to permanent nicotine dependence, and Clinicians should not recommend e-cigarette users forsmoking cessation due to the risk of permanent Nicotine dependence.
Electronic Cigarettes Efficacy and Safety at 12 Months: Cohort Study
If e-cigarette safety will be confirmed, however, the use of e-cigarettes alone may facilitate quitters remaining so, although e-smokers showed a minimal but significantly higher increase in self-rated health than other smokers.
A Pragmatic Trial of E‐Cigarettes, Incentives, and Drugs for Smoking Cessation
In this pragmatic trial of smoking cessation, financial incentives added to free cessation aids resulted in a higher rate of sustained smoking abstinence thanfree cessation aids alone.


Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial
The 16 mg Ruyan V8 ENDD alleviated desire to smoke after overnight abstinence, was well tolerated and had a pharmacokinetic profile more like the Nicorette inhalator than a tobacco cigarette.
Effect of a nicotine-free inhalator as part of a smoking-cessation programme
The results of the logistic model analysis indicate that a high GN-SBQ score is a strong independent predictor for successful quitting at 24 weeks in the PAIPO group, and nicotine-free inhalators may be beneficial when used in the context of smoking-cessation interventions.
Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study
Long-term e-Cigarette use can substantially decrease cigarette consumption in smokers not willing to quit and is well tolerated.
Nicotine replacement therapy in smoking cessation.
Evidence for benefit from nicotine replacement therapy in hospital patients is inconclusive, although the results of a trial reported in this issue of Thorax give cause for optimism and should
Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?
NRT for aiding smoking reduction appeared to be safe, was associated with a clinically significant reduction in smoke exposure over a five-week follow up, and increased motivation to stop smoking.
Real-world efficacy of prescription and over-the-counter nicotine replacement therapy.
Smoking cessation rates achieved with nicotine gum and patch under OTC conditions were as good as those under real-world prescribing conditions.
Outcome criteria in smoking cessation trials: proposal for a common standard.
Six standard criteria comprising the 'Russell Standard' (RS) are proposed and it is believed that these criteria provide the best compromise between practicability and surrogacy for long-term cessation and will enable meaningful comparison between studies.
New Zealand smoking cessation guidelines.
Key recommendations made in the 2007 New Zealand Smoking Cessation Guidelines are summarized to assist healthcare professionals in providing evidence-based smoking cessation support to people who smoke.
Nicotine levels in electronic cigarettes.
In ECs, which vaporize nicotine effectively, the amount inhaled from 15 puffs is lower compared with smoking a conventional cigarette, but EC brands and models differ in their efficacy and consistency of nicotine vaporization.
The Autonomy Over Smoking Scale.
The Autonomy Over Smoking Scale was produced through a process involving item generation, focus-group evaluation, testing in adults to winnow items, field testing with adults and adolescents, and head-to-head comparisons with other measures.